WO2014052766A1 Hepatocyte growth factor mimics as therapeutic agents Google Patents Diabetic kidney disease (DKD) is usually a clinical diagnosis in a patient with long standing diabetes (>10 years) with albuminuria and or reduced estimated glomerular filtration rate (eGFR) in the absence of signs or The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Frontiers Acute Kidney Injury in Pediatric Diabetic Kidney Disease Hepatocyte Growth Factor MET Activator Rescues Working Memory Deficits after Repeated Mild Traumatic Brain Injury Katelyn A. Martino, Arush Nakhre, Renee M. Demarest, David M. Devilbiss, 2025